1. Ciencia

INTERNATIONAL
SYMPOSIUM
ON CANCER
IMMUNOLOGY AND
IMMUNOTHERAPY:
Breakthroughs in cancer immunology
research have led to the emergence of
cancer immunotherapy as a new class of
treatment for a variety of malignancies.
Amplification of tumor-specific T cells and
blockade of T cell inhibitory signals have
been demonstrated to eliminate primary
and disseminated tumors, conferring
durable clinical responses to cancer
patients. This international symposium will
discuss cutting-edge research topics on
the induction and regulation of antitumor
T cell immunity as well as the recent
advances made in the revolutionary field of
cancer immunotherapy.
TRANSLATING BASIC SCIENCE INTO NEXT GENERATION THERAPIES
18 DECEMBER 2014
FUNDACIÓN CIENCIA & VIDA, SANTIAGO, CHILE
SPEAKERS:
Fabiola Osorio, PhD
Flavio Salazar, PhD
Sergio Quezada, PhD
Alvaro Lladser, PhD
Daniela Sauma, PhD
Mark Selby, PhD
Tumor Immunology and
Immunotherapy Laboratory
Facultad de Medicina, Universidad
de Chile, Santiago, Chile.
Gene Immunotherapy Laboratory
Fundación Ciencia & Vida,
Santiago, Chile.
Tumor Immunology and
Immunotherapy Laboratory
Facultad de Medicina, Universidad
de Chile, Santiago, Chile.
Immunology Laboratory.
Facultad de Ciencias, Universidad
de Chile, Santiago, Chile.
Immune Regulation and Tumour
Immunology Laboratory
University College London,
Cancer Institute, London, UK.
Director, Cell Biology &
Immunology
Bristol-Myers Squibb, Milpitas,
California, USA.
CONTACT:
Dr. Alvaro Lladser,
Fundación Ciencia & Vida
[email protected]
www.cienciavida.cl
www.inmunoterapia.cl
Free registration.
Limited number of
participants.